DrugChatter: Has ruxolitinib’s generic entry led to significant cost reductions?
Short answer: in the United States, as of mid-2024 there was no US-approved generic ruxolitinib on the market, so there had… https://www.Drugchatter.com/chat/41682/has-ruxolitinib’s-generic-entry-led-to-significant-cost-reductions/
DrugChatter: Has ruxolitinib’s generic entry led to significant cost reductions? Read Post »
